TrialClinical and translational science2025

Association of SULT2A1 Locus With Abiraterone Clearance in the Alliance A031201: Randomized Phase III Study of Enzalutamide Compared With Enzalutamide Plus Abiraterone for Metastatic Castration-Resistant Prostate Cancer.

Nadine Norton et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.